Milestone Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Milestone Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Milestone Pharmaceuticals Inc
Rating: 0.84341675
Author: Trendlyne DVM scores

about

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-admini...

0.92 0.00 (0.00%)

New 52W Low in past week

673.9K

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.7 / 100

Technically Bearish

26.1 / 100

1Yr Price target upside is 537%

7 analysts

Milestone Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Milestone Pharma Inc Live Stock Price Today, Share Analysis and Chart

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-admini...

New 52W Low in past week

SWOT Analysis

Milestone Pharma Inc Live Price Chart

Milestone Pharma Inc Live Price Chart